The US Food and Drug Administration today finalized its rules for the creation of a new class of over-the-counter (OTC) hearing aids that is designed to make amplification more affordable and accessible to consumers (ages 18+) with mild to moderate hearing loss....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
Clinicians should prepare to counsel patients on differences between OTC and prescription hearing aids, update practice protocols for managing self-fitted devices, and reassess business models accordingly.
The OTC hearing aid rule is the most significant regulatory change in U.S. hearing healthcare in decades, fundamentally reshaping patient access, the retail landscape, and the clinical role of audiologists.
- 01FDA finalized rules creating a new OTC hearing aid category for adults with mild-to-moderate hearing loss.
- 02Adults can now purchase OTC hearing aids without a prescription or professional evaluation.
- 03The rule aims to increase affordability and accessibility of hearing amplification.
- 04OTC devices are distinct from prescription hearing aids and personal sound amplification products (PSAPs).
- 05The change has major implications for audiology clinic business models and patient counselling.
OTC hearing aids will increase affordability and accessibility of amplification for adults with mild-to-moderate hearing loss.
guidelinepartially supportedFDA established a distinct regulatory category for OTC hearing aids separate from prescription devices.
guidelinesupported
